Catalyst
Slingshot members are tracking this event:
Adaptimmune (ADAP) Presents on NY-ESO Therapy in Patients With Synovial Sarcoma and Myeloma at 2015 Annual Meeting of the Society of Immunotherapy for Cancer (SITC)
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ADAP |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 05, 2015
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Ny-eso, Synovial Sarcoma, Myeloma, Affinity Enhanced T-cell Therapy, Mage A-10
